Pfizer Inc.’s covid-19 vaccine remained highly effective after six months, according to new long-term results that the company said could be used to seek an expansion of its regulatory status.
Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11. The results mark a key step in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback